Aptuit plans job cuts

Aptuit says it is planning to cut jobs in the U.K., but hasn't said how many workers face the axe, saying only that it is repositioning its resources in light of current economic conditions. The U.S. company does R&D and clinical packaging work in the U.K. Report

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.